N/A N=79 Randomized Quadruple-blind Treatment

Treatment of Androgenic Alopecia in Males

Androgenetic Alopecia · Hair Loss · Male Pattern Baldness

Bottom Line

View on ClinicalTrials.gov: NCT00947219 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jan 2013

Primary outcome: Primary: Changes in Terminal Hair Count at 16 and 26 Weeks Compared to Baseline in Men Diagnosed With Androgenetic Alopecia — 23.5; 20.4; 4.4; 25.7 hairs per cm^2

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: HairMax LaserComb (Device); Control device (Device)
Age: Adult · 25+ yrs
Sex: Male
Sponsor: Lexington International, LLC
Primary completion: Aug 2010

Outcome Measures

Outcome	Result	p-value
PRIMARY Changes in Terminal Hair Count at 16 and 26 Weeks Compared to Baseline in Men Diagnosed With Androgenetic Alopecia	23.5; 20.4; 4.4; 25.7; 20.9; 9.4	—

Summary

The purpose of this study is to evaluate the change in terminal hair count at 16 and 26 weeks compared to baseline measurements.

Eligibility Criteria

Inclusion Criteria

Diagnosis of androgenetic alopecia
Fitzpatrick Skin Types I-IV
Norwood-Hamilton IIa to V
Active hair loss within last 12 months

Exclusion Criteria

Photosensitivity to laser light
Malignancy in the target area

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00947219). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.